Views
4 years ago

04 - Junio 2000

  • Text
  • Secretasas
  • App
  • Precursor
  • Amiloide
  • Amyloid
  • Presenilins
  • Alzheimer
  • Genes
  • Formas
  • Enfermedad
  • Presenilinas
  • Notch
Presenilinas y demencia: Interfaz molecular entre genes y enfermedad de Alzheimer

Oyama F, Sawamura N,

Oyama F, Sawamura N, Kobayashi K, Morishima-Kawashima T, Ito M, y cols: Mutant presenilin 2 transgenic mouse: effects on a age-dependent increase of amyloid beta-protein 42 in the brain. J Neuroschem 1998; 71(1): 313-322. Racchi M, Govoni S; Rationalizing a pharmacological intervention on the amyloid precursor protein metabolism. Trends pharmacol Sci 1999; 20(10): 418-423. Ray WJ, Ashall F, Goate AM: Molecular pathogenesis of sporadic and familial forms of Alzheimer’s diases. Mol Med Today 1998; 4(4): 151-157. Ribaut-Barassin C, Moussaaoui S, Brugg B; Haeberle AM, Huber G, y cols: Hemisynaptic distribution patterns of presenilns and bete-APP isoforms in the rodent cerebellum and hoppocampus. Synapse 2000; 35(2): 96- 110. Savioz A, Leuba G, Forsell C, Lilius L, Rossier C, y cols: No detected mutations in the genes for the amyloid precursor protein and presenilins 1 and 2 in a swiss early onset Alzheimer’s disease family with a dominant mode of inheritance. Dement Geriatr Cogn Disord 1999; 10(6): 431-436. Schapiro L, Colman DR: Structural biology of cadherins in the nervous system. Curr Opin Neurobiol 1998; 8(5): 593-599. Selkoe DJ: Notch and presenilins in vertebrates and invertebrates: implication for neuronal development and degeneration. Curr Opin Neurobiol 2000; 10(1): 50-57. Selkoe DJ: Translating cell bology into therapeutic 399 (Suppl 6738): A23-A31. Slack BE, Breu J, Petrybiak MA, Srivastava E, Wurtman RJ: Tyrosine phosphotyrilation-dependant stimulation of amyloid precursor protein secretion by the M3 muscarinic acetylcholine receptor. J Biol Chem 1995; 270(14): 8337-8344. Sloop GD: Cellular pathogenesis of Alzheimer’s disease. Med Hypotheses 1999; 53(2): 127-129. Steiner H, Capell A, Leimer U, Haass C: Genes and mechanisms involved in beta-amyloid- generation and Alzheimers disease. Eur Arch Psychiatry Clin Neurisci 1999; 249(6): 266-270. Steiner H, Romig H, Pesold B, Philipp U, Baader M, y cols: Amyloidogenic function of the Alzheimer’s diseaseassociated presenilin 1 in the absence of endoproteolysis. Biochemistry 1999; 38(44): 14600-14605. Thinikaran G: The role of prenenilins in Alzheimers disease. J Clin Invest 1999; 104(10): 1321-1327. Wolfe MS, Xia W, Ostaszewski BL, Diehl TS, Kimberly WT, Selkoe DJ: Two Transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secreatase activity. Nature 1999; 398: 513- 517. Yu G, Chen F, Levesque G, Nishimura M, Zhang DM, y cols: The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains beta-catenin. J Biol Chem 1998; 273(26): 16470-16475.

Biblioteca

Av. García del Río 2585 Piso 12 A - C.A.B.A
+54 11 2092 1646 | info@sciens.com.ar

Editorial Sciens, Todos los Derechos Reservados 2015